Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group PLC, a global leader in animal pharmaceuticals, has distributed its Annual Report and Accounts for the year ending March 31, 2024, to its shareholders and has made it available on their website. The company, known for its comprehensive veterinary products and a developing R&D pipeline, will also convene its Annual General Meeting in London on September 26, 2024. ECO specializes in veterinary pharmaceuticals with a focus on antibiotics and vaccines, particularly for pigs and poultry, and markets its flagship product Aivlosin® in over 70 countries.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
